SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-001048
Filing Date
2019-01-11
Accepted
2019-01-11 17:07:32
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4059
  Complete submission text file 0000899243-19-001048.txt   5825
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 400 ROYAL PALM WAY SUITE 212 PALM BEACH FL 33480
Business Address 400 ROYAL PALM WAY SUITE 212 PALM BEACH FL 33480 561 300 4860
Vatera Capital Management LLC (Reporting) CIK: 0001764047 (see all company filings)

State of Incorp.: CT | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 19522857